Quantcast

FDA To Decide On New Diet Pill while Fen Phen Linked to Severe Adverse Events

June 14, 2012

On June 27th, 2012, the US FDA is set to decide on new obesity drug Lorcaserin. In the briefing documents for the May 10th, 2012 meeting of the FDA Endocrinologic and Metabolic Drugs Advisory Committee, reviewers expressed concerns on safety of Lorcaserin related mainly to heart problems. The FDA originally declined to approve the drug in 2010 because of concerns including potential effects on patients’ hearts. Another obesity drug, the popular Fen Phen, was withdrawn from the market in 1997 after it was linked with heart valve damage and primary pulmonary hypertension (PPH). Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Fen Phen severe adverse events. [http://www.attorneyone.com/fen-phen-lawsuits/ .

San Diego, CA (PRWEB) June 14, 2012

The media spotlight is often a double-edged sword. No one knows this better than people who suffer from Fen Phen severe adverse events. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne. On June 27th, 2012, the US FDA is set to decide on new obesity drug Lorcaserin.

In the briefing documents for the May 10th, 2012 meeting of the FDA Endocrinologic and Metabolic Drugs Advisory Committee, reviewers expressed concerns on safety of Lorcaserin related mainly to heart problems. The FDA originally declined to approve the drug in 2010 because of concerns including potential effects on patients’ hearts. On July 17th, 2012 the FDA is also set to decide on Vivus Inc.´s Qnexa obesity drug.

Another obesity drug, the popular Fen Phen, was withdrawn from the market in 1997 after it was linked with heart valve damage and primary pulmonary hypertension (PPH). Fen Phen was very popular in the mid-1990s among patients who were seeking a fast and easy way to lose weight. The Centers for Diseases Control and Prevention in Atlanta reported that more than one-third of US adults and almost 17% of youth were obese in 2009—2010.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of Fen Phen severe complications, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Fen Phen remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

According to a study published in BMC Medicine in 2008, many individuals that had taken Fen Phen in the past suffered heart valve damage that appeared up to 7 years later.

AttorneyOne informs that if someone has already filed a claim and received a settlement but their condition deteriorated overtime they may be eligible for further compensation.

AttorneyOne.com has further information on Fen Phen lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/6/prweb9598833.htm.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/6/prweb9602956.htm


Source: prweb



comments powered by Disqus